315 related articles for article (PubMed ID: 21993194)
21. CGRPα within the Trpv1-Cre population contributes to visceral nociception.
Spencer NJ; Magnúsdóttir EI; Jakobsson JET; Kestell G; Chen BN; Morris D; Brookes SJ; Lagerström MC
Am J Physiol Gastrointest Liver Physiol; 2018 Feb; 314(2):G188-G200. PubMed ID: 28971837
[TBL] [Abstract][Full Text] [Related]
22. Isopentenyl pyrophosphate is a novel antinociceptive substance that inhibits TRPV3 and TRPA1 ion channels.
Bang S; Yoo S; Yang TJ; Cho H; Hwang SW
Pain; 2011 May; 152(5):1156-1164. PubMed ID: 21353389
[TBL] [Abstract][Full Text] [Related]
23. TRP channels: targets for the relief of pain.
Levine JD; Alessandri-Haber N
Biochim Biophys Acta; 2007 Aug; 1772(8):989-1003. PubMed ID: 17321113
[TBL] [Abstract][Full Text] [Related]
24. Gain-of-function mutations in the transient receptor potential channels TRPV1 and TRPA1: how painful?
Boukalova S; Touska F; Marsakova L; Hynkova A; Sura L; Chvojka S; Dittert I; Vlachova V
Physiol Res; 2014; 63(Suppl 1):S205-13. PubMed ID: 24564660
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous nociception evoked by 15-delta PGJ2 via activation of ion channel TRPA1.
Cruz-Orengo L; Dhaka A; Heuermann RJ; Young TJ; Montana MC; Cavanaugh EJ; Kim D; Story GM
Mol Pain; 2008 Jul; 4():30. PubMed ID: 18671867
[TBL] [Abstract][Full Text] [Related]
26. TRPA1 receptor localisation in the human peripheral nervous system and functional studies in cultured human and rat sensory neurons.
Anand U; Otto WR; Facer P; Zebda N; Selmer I; Gunthorpe MJ; Chessell IP; Sinisi M; Birch R; Anand P
Neurosci Lett; 2008 Jun; 438(2):221-7. PubMed ID: 18456404
[TBL] [Abstract][Full Text] [Related]
27. Warmth suppresses and desensitizes damage-sensing ion channel TRPA1.
Wang S; Lee J; Ro JY; Chung MK
Mol Pain; 2012 Mar; 8():22. PubMed ID: 22458587
[TBL] [Abstract][Full Text] [Related]
28. Selective blockade of TRPA1 channel attenuates pathological pain without altering noxious cold sensation or body temperature regulation.
Chen J; Joshi SK; DiDomenico S; Perner RJ; Mikusa JP; Gauvin DM; Segreti JA; Han P; Zhang XF; Niforatos W; Bianchi BR; Baker SJ; Zhong C; Simler GH; McDonald HA; Schmidt RG; McGaraughty SP; Chu KL; Faltynek CR; Kort ME; Reilly RM; Kym PR
Pain; 2011 May; 152(5):1165-1172. PubMed ID: 21402443
[TBL] [Abstract][Full Text] [Related]
29. Dynamic changes in the TRPA1 selectivity filter lead to progressive but reversible pore dilation.
Banke TG; Chaplan SR; Wickenden AD
Am J Physiol Cell Physiol; 2010 Jun; 298(6):C1457-68. PubMed ID: 20457836
[TBL] [Abstract][Full Text] [Related]
30. Molecular characterization of TRPA1 channel activation by cysteine-reactive inflammatory mediators.
Takahashi N; Mizuno Y; Kozai D; Yamamoto S; Kiyonaka S; Shibata T; Uchida K; Mori Y
Channels (Austin); 2008; 2(4):287-98. PubMed ID: 18769139
[TBL] [Abstract][Full Text] [Related]
31. TRPV1 and TRPA1 mediate peripheral nitric oxide-induced nociception in mice.
Miyamoto T; Dubin AE; Petrus MJ; Patapoutian A
PLoS One; 2009 Oct; 4(10):e7596. PubMed ID: 19893614
[TBL] [Abstract][Full Text] [Related]
32. The peptide Phα1β, from spider venom, acts as a TRPA1 channel antagonist with antinociceptive effects in mice.
Tonello R; Fusi C; Materazzi S; Marone IM; De Logu F; Benemei S; Gonçalves MC; Coppi E; Castro-Junior CJ; Gomez MV; Geppetti P; Ferreira J; Nassini R
Br J Pharmacol; 2017 Jan; 174(1):57-69. PubMed ID: 27759880
[TBL] [Abstract][Full Text] [Related]
33. Emergence of functional sensory subtypes as defined by transient receptor potential channel expression.
Hjerling-Leffler J; Alqatari M; Ernfors P; Koltzenburg M
J Neurosci; 2007 Mar; 27(10):2435-43. PubMed ID: 17344381
[TBL] [Abstract][Full Text] [Related]
34. Modulation of transient receptor vanilloid 1 activity by transient receptor potential ankyrin 1.
Spahn V; Stein C; Zöllner C
Mol Pharmacol; 2014 Feb; 85(2):335-44. PubMed ID: 24275229
[TBL] [Abstract][Full Text] [Related]
35. The TRPA1 channel mediates the analgesic action of dipyrone and pyrazolone derivatives.
Nassini R; Fusi C; Materazzi S; Coppi E; Tuccinardi T; Marone IM; De Logu F; Preti D; Tonello R; Chiarugi A; Patacchini R; Geppetti P; Benemei S
Br J Pharmacol; 2015 Jul; 172(13):3397-411. PubMed ID: 25765567
[TBL] [Abstract][Full Text] [Related]
36. Transient receptor potential ion channels: powerful regulators of cell function.
Billeter AT; Hellmann JL; Bhatnagar A; Polk HC
Ann Surg; 2014 Feb; 259(2):229-35. PubMed ID: 23989052
[TBL] [Abstract][Full Text] [Related]
37. Activation of TRPV1 and TRPA1 leads to muscle nociception and mechanical hyperalgesia.
Ro JY; Lee JS; Zhang Y
Pain; 2009 Aug; 144(3):270-277. PubMed ID: 19464796
[TBL] [Abstract][Full Text] [Related]
38. General anesthetics activate a nociceptive ion channel to enhance pain and inflammation.
Matta JA; Cornett PM; Miyares RL; Abe K; Sahibzada N; Ahern GP
Proc Natl Acad Sci U S A; 2008 Jun; 105(25):8784-9. PubMed ID: 18574153
[TBL] [Abstract][Full Text] [Related]
39. Potential therapeutic value of TRPV1 and TRPA1 in diabetes mellitus and obesity.
Derbenev AV; Zsombok A
Semin Immunopathol; 2016 May; 38(3):397-406. PubMed ID: 26403087
[TBL] [Abstract][Full Text] [Related]
40. TNF-α-induced p38MAPK activation regulates TRPA1 and TRPV4 activity in odontoblast-like cells.
El Karim I; McCrudden MT; Linden GJ; Abdullah H; Curtis TM; McGahon M; About I; Irwin C; Lundy FT
Am J Pathol; 2015 Nov; 185(11):2994-3002. PubMed ID: 26358221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
